Development of a deep‐learning model tailored for <scp>HER2</scp> detection in breast cancer to aid pathologists in interpreting <scp>HER2</scp>‐low cases

Abstract

Deep learning can support pathologists' interpretation of difficult HER2-low cases. Morphological variables and some specific artefacts can cause discrepant HER2-scores between the pathologist and the DL model.